Drug Safety Information for BYETTA (Exenatide synthetic)

FDA Safety-related Labeling Changes for BYETTA (EXENATIDE SYNTHETIC) Rx Drug: Safety Information Link

FDA Safety-related Labeling Changes for BYETTA (EXENATIDE SYNTHETIC) Rx Drug: Safety Information Link

FDA Safety-related Labeling Changes for BYDUREON (EXENATIDE SYNTHETIC) Rx Drug: Safety Information Link

FDA Safety-related Labeling Changes for BYDUREON (EXENATIDE SYNTHETIC) Rx Drug: Safety Information Link

Required post-approval safety study:

Deferred pediatric study under PREA for the treatment of type 2 diabetes mellitus in pediatric patients ages 10 to 16 years (inclusive). Due Date: 2020-07-31

Original FDA Drug Approval Date for BYETTA: 2005-04-28

Adverse Drug Reactions for BYETTA* (Exenatide synthetic)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with BYETTA
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Blood glucose increased15533
2Weight decreased*12526
3Nausea*12440
4Decreased appetite*6704
5Blood glucose decreased5513
6Vomiting*4482
7Diarrhoea*2898
8Dizziness*2693
9Injection site pain2500
10Injection site haemorrhage2285
11Drug ineffective2222
12Pancreatitis2182
13Injection site haematoma2156
14Headache*2148
15Fatigue1758
16Feeling abnormal1601
17Asthenia1564
18Drug effect decreased1548
19Malaise*1517
20Tremor1508

* This side effect also appears in "Top 10 Side Effects of BYETTA " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking BYETTA
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Type 2 diabetes mellitus132432
2Diabetes mellitus*10814
3Product used for unknown indication7468
4Insulin-requiring type 2 diabetes mellitus2534
5Type 1 diabetes mellitus*1142
6Weight decreased*1020
7Glucose tolerance impaired889
8Insulin resistance*479
9Weight control404
10Obesity222

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for BYETTA

Total Reports Filed with FDA: 187477


Number of FDA Adverse Event Reports by Patient Age for BYETTA

Total Reports Filed with FDA: 187477*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Exenatide synthetic (Byetta, Bydureon)

Charts are based on 187477 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and BYETTA Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.